StockData
Nkarta, Inc. logo

Nkarta, Inc. (NKTX) stock

NKTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30
$1.15−0.10 (-8.00%)

Close on Nov 18, 2026Market cap $82.37MP/E –Yield 0.00%

Nkarta price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

No price to sales ratio figures for Nkarta

Nkarta has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Nkarta figures

See a number that looks wrong?